Skip to content

    NRC HEALTH (NRC) stock price & financials

    View NRC earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+41.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $35.82M
    $36.91M
    $33.55M
    $34.04M
    $34.61M
    -3.4%
    $35.19M
    -4.6%
    $34.80M
    +3.7%
    $35.39M
    +4.0%
    Stable
    Operating Profit
    $7.98M
    $9.59M
    $8.60M
    $1.59M
    $7.74M
    -3.0%
    $4.67M
    -51.3%
    $5.57M
    -35.2%
    -$3.24M
    -303.9%
    Weakening
    Net Profit
    $5.79M
    -$106.0K
    $3.22M
    -44.3%
    -$3.28M
    -2997.2%
    Weakening
    EPS
    $0.24
    $0.25
    $-0.01
    $0.18
    -25.0%
    $0.14
    -44.0%
    $-0.15
    -1400.0%
    Weakening
    Other Income
    -$684.0K
    -$713.0K
    -$873.0K
    -$1.01M
    -$1.47M
    -114.2%
    -$1.40M
    -96.4%
    -$1.19M
    -36.3%
    -$1.30M
    -29.0%
    Weakening
    Interest
    $706.0K
    $729.0K
    $899.0K
    $1.03M
    $1.46M
    +106.9%
    $1.37M
    +87.8%
    $1.25M
    +39.6%
    $1.32M
    +28.0%
    Strengthening
    Depreciation
    Profit before Tax
    $7.30M
    $8.88M
    $7.72M
    $581.0K
    $6.27M
    -14.0%
    $3.27M
    -63.2%
    $4.38M
    -43.3%
    -$4.54M
    -880.9%
    Weakening
    MarginsOPM
    22.3%
    26.0%
    25.6%
    4.7%
    22.4%
    +0.4%
    13.3%
    -49.0%
    16.0%
    -37.5%
    -9.2%
    -295.9%
    Weakening
    Tax
    22.0%
    26.1%
    25.1%
    118.2%
    34.3%
    +55.6%
    45.0%
    +72.6%
    26.4%
    +5.4%
    27.6%
    -76.6%
    Stable
    ReturnsROIC
    -23.6%
    0.4%
    -13.2%
    +44.3%
    13.4%
    +2997.2%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$12.99M$13.52M$34.69M$54.36M$25.03M$6.65M$4.23M$4.14M$3.33M
    Short-Term Investments
    Total Current Assets$28.41M$29.16M$54.11M$73.71M$43.72M$24.36M$19.60M$20.21M$22.81M
    Net PP&E$14.15M$15.16M$13.03M$13.37M$17.80M$30.27M$39.90M$41.63M$39.50M
    Goodwill$57.83M$57.94M$57.26M$61.61M$61.61M$61.61M$66.15M$66.15M$66.15M
    Intangibles$2.10M$1.73M$1.41M$1.79M$1.61M$1.47M$2.62M$2.23M$2.10M
    Total Assets$108.03M$110.69M$133.42M$157.54M$130.46M$122.44M$132.54M$134.88M$136.15M
    LiabilitiesTotal Current Liabilities$47.11M$38.16M$31.68M$40.39M$33.42M$36.20M$35.86M$36.62M$35.02M
    Short-Term Debt$4.01M$4.02M
    Long-Term Debt$34.18M$29.80M$26.55M$26.62M$22.32M$29.47M$57.90M$75.02M$86.01M
    Long-Term Leases$1.65M$1.16M$744.0K
    Total Liabilities$88.95M$77.79M$69.11M$72.20M$58.43M$73.48M$101.25M$120.89M$129.60M
    EquityCommon Stock & APIC$30.0K$30.0K$31.0K$31.0K$31.0K$31.0K$31.0K$32.0K$32.0K
    Retained Earnings-$106.34M-$93.36M-$61.38M-$36.11M-$25.18M-$30.53M-$17.06M-$17.30M-$24.51M
    Total Equity$19.08M$32.89M$64.31M$85.34M$72.03M$48.95M$31.28M$13.99M$6.55M
    HighlightsNet Cash / (Debt)-$74.90M-$86.70M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$39.85M$40.92M$40.64M$46.34M$36.27M$38.11M$34.63M$26.45M$29.51M
    Cash from Investing-$5.97M-$4.66M-$3.72M-$8.51M-$9.84M-$15.78M-$20.28M-$10.71M-$7.87M
    Cash from Financing-$54.50M-$36.35M-$15.50M-$18.16M-$55.58M-$40.71M-$16.76M-$15.84M-$23.59M
    SummaryCapital Expenditure-$5.97M-$4.66M-$3.98M-$5.51M-$9.84M-$15.78M-$15.45M-$10.71M-$7.87M
    Free Cash Flow$33.88M$36.26M$36.65M$40.83M$26.43M$22.33M$19.18M$15.74M$21.64M
    FCF Margin28.3%28.3%27.5%27.6%17.4%15.0%13.4%11.5%15.5%

    Ratios